Treatment of aspergillosis.
Karthaus
Meinolf
M
D000935:Antifungal Agents / Q000009:adverse effects*; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D015725:Fluconazole / Q000009:adverse effects; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D009190:Myelodysplastic Syndromes / Q000150:complications; D009503:Neutropenia / Q000150:complications; D014230:Triazoles / Q000009:adverse effects*
D000935:Antifungal Agents; D014230:Triazoles; D017964:Itraconazole; C101425:posaconazole; D015725:Fluconazole